Wolfgang Simon
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 12
- Oncology 21
- Cancer Treatment and Pharmacology 10
- Cancer Cells and Metastasis 6
- HER2/EGFR in Cancer Research 4
- Cancer Risks and Factors 3
- Co-authors
- Werner SchrothPéter FritzHiltrud BrauchMatthias SchwabMichel EichelbaumF. HölzelThomas MuerdterUlrich M. Zanger
- Journals
- Journal of Clinical Oncology (7 papers)Journal of Cancer Research and Clinical Oncology (5 papers)Cancer Research (4 papers)BMC Cancer (2 papers)Journal of Molecular Medicine (2 papers)
- Partner nations
- GermanyUnited StatesChile
In The Last Decade
Wolfgang Simon
44 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Pharmacology 404
- Oncology 495
- Genetics 493
- Cancer Research 188
- Cellular and Molecular Neuroscience 190
Countries citing papers authored by Wolfgang Simon
This map shows the geographic impact of Wolfgang Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Simon more than expected).
Fields of papers citing papers by Wolfgang Simon
This network shows the impact of papers produced by Wolfgang Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Simon. The network helps show where Wolfgang Simon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wolfgang Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 9 | |
| 2 | 2011 | 2 | |
| 3 | 2011 | 1 | |
| 4 | 2010 | 1 | |
| 5 | 2008 | 52 | |
| 6 | 2008 | 18 | |
| 7 | 2008 | 5 | |
| 8 | 2007 | 336 | |
| 9 | Final toxicity analysis of the ADEBAR phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement | 2007 | 1 |
| 10 | 2007 | 20 | |
| 11 | 2006 | 85 | |
| 12 | 2005 | 57 | |
| 13 | 1993 | 1 | |
| 14 | 1992 | 38 | |
| 15 | 1992 | 10 | |
| 16 | 1991 | 46 | |
| 17 | 1989 | 2 | |
| 18 | 1985 | 22 | |
| 19 | [Is there good correlation between findings in lumbar myelography and surgery? (author's transl)]. | 1981 | 3 |
| 20 | [Clinical study on the development of dependency after long-term treatment with tramadol (author's transl)]. | 1978 | 19 |
About Wolfgang Simon
Wolfgang Simon is a scholar working on Cancer Research, Oncology, Classics, Transplantation and Pharmacology, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (10 papers), Estrogen and related hormone effects (7 papers), Cancer Cells and Metastasis (6 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Risks and Factors (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Pharmacology (404 citations), Oncology (495 citations), Genetics (493 citations), Cancer Research (188 citations) and Cellular and Molecular Neuroscience (190 citations). Wolfgang Simon has collaborated with scholars based in Germany, United States and Chile. Frequent co-authors include Werner Schroth, Péter Fritz, Hiltrud Brauch, Matthias Schwab, Michel Eichelbaum, F. Hölzel, Thomas Muerdter, Ulrich M. Zanger, Detlev Ganten and G. Stock. Their work appears in journals such as Journal of Clinical Oncology, Journal of Cancer Research and Clinical Oncology, Cancer Research, BMC Cancer and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.